Inhaler
Latest Novartis AG Patents:
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant fc fusion proteins
- Pharmaceutical products and stable liquid compositions of IL-17 antibodies
- Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
- Injection device and injection solution transferring system
- Stable, concentrated radiopharmaceutical composition
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D614285
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Apr 20, 2010
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Sandra S. Shim
Application Number: 29/292,809
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Apr 20, 2010
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Sandra S. Shim
Application Number: 29/292,809
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)